Staff members (REF1a/c)
1 - Clinical Medicine
University of Edinburgh
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
Profile:
Professor Ian Kunkler is Consultant in Clinical Oncology at Edinburgh Cancer Research Centre and Professor of Clinical Oncology.
Research and links to the UoA:
He is chief investigator on several radiotherapy trials in early breast cancer. The PRIME 2 trial (CSO-funded) addressed the question of whether routine radiotherapy is necessary in older patients with low risk breast cancer, and reports at the end of 2013. The SUPREMO trial (MRC funded),asking if radiotherapy improves survival in patients following mastectomy with moderate risk disease, has completed recruitment internationally.
He is co-applicant on: the EU-funded METOXIA programme exploring hypoxia in cancer, in collaboration with Langdon (IGMM), et al; the ESPRC-funded IMPACT programme to develop robotic control of radiotherapy in collaboration with Murray and Walton (UoE Engineering), van Beek, CRIC, Bradley (Chemistry), Argyle (Veterinary Medicine) et al; and the FP7-funded RARECARENet project.
Exemplar outputs:
- Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as driver of progression, J Pathol. 2012 Aug; 227(4):481-9.
- Impact of screening and risks factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer, Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):829-38.
Further information:
http://www.iankunkler.org.uk/
http://www.ecrc.ed.ac.uk/Research/item/Prof-Ian-Kunkler.html
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
Profile:
Professor Clifford Leen is Consultant Physician in Infectious Diseases, Principal Investigator in the Division of Pathway Medicine and Honorary Professor at the University of Edinburgh. He is on the Scientific steering committee of the UK Register of Acute HIV seroconverters; UK CHIC; and HCV Research UK.
Research and links to the UoA:
Professor Leen leads research activities in HIV and other chronic viral infections, including those mediated by hepatotropic viruses. He is closely involved in clinical trials and works collaboratively with colleagues in Pathway Medicine on aspects of viral infection/the antiviral response. The research unit conducts clinical trials of antimicrobial agents, antiviral, antifungal and antibiotics. He takes part in EUROSIDA, & DAD studies and other multi-centre studies.
He is a member of the Division of Pathway Medicine and Honorary Professor at the University of Edinburgh. He collaborates with Ghazal et al in the Division of Pathway Medicine and Hayes et al in the MRC Centre for Inflammation Research. His research is carried out at the Western General Hospital, Edinburgh.
Further information:
http://www.ed.ac.uk/news/staff/clifford-leen-140709
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine
- B - The Queen's Medical Research Institute
- B - The Queen's Medical Research Institute
- A - The Institute for Genetics & Molecular Medicine
- A - The Institute for Genetics & Molecular Medicine